AG真人官方

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 18, 2025

Air Products and Chemicals, Inc.

(Exact name of registrant as specified in charter)

1940 Air Products Boulevard Allentown,

Pennsylvania 18106-5500

(Address of principal executive offices and Zip Code)

(610) 481-4911

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 under the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

On August 18, 2025, the board of directors (the “Board”) of Air Products and Chemicals, Inc. (the “Company”) elected Howard Ungerleider as a director of the Company, effective September 1, 2025. Mr. Ungerleider, 56, is an Operating Advisor at Clayton, Dubilier & Rice, a leading private equity firm, and previously served from 2018 to 2023 as President and from 2014 to 2023 as Chief Financial Officer of Dow Inc. and its predecessors.

In connection with Mr. Ungerleider’s election, the Board considered his independence under New York Stock Exchange listing standards and the Company’s Corporate Governance Guidelines and concluded that he will be an independent director under these standards. The Board assigned Mr. Ungerleider to serve as a member of its Audit and Finance Committee, also effective September 1, 2025.

Mr. Ungerleider will receive compensation and be subject to indemnification for serving as a member of the Board consistent with the Company’s normal arrangements for non-employee directors, which are described in the Company’s definitive proxy statement for its 2025 annual meeting of shareholders. There are no arrangements or understandings between Mr. Ungerleider and any other person pursuant to which Mr. Ungerleider was elected as a director, and neither Mr. Ungerleider nor any of his immediate family members is a party, either directly or indirectly, to any transaction that would be required to be reported under Item 404(a) of Regulation S-K.

A copy of the Company’s press release announcing the election of Mr. Ungerleider is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

(d) Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.